INNOCARE 09969Hong Kong Stock Exchange

12.7301.52%( +0.190 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
INNOCARE (09969) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-03-23
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG4783B1032
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)2.78B37/112
Net Profit (Last FY)753.40M24/125
ROE (Last FY)8.31%32/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Jisong Cui Executive Director
Renbin Zhao Executive Director
Yigong Shi Non-Executive Director
Ronggang Xie Non-Executive Director
Lan Hu Independent Non-Executive Director
Dandan Dong Independent Non-Executive Director
Kunliang Guan Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-11-13.

About this page

This page shows INNOCARE (09969) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.